Michael B. Yaffe | |
---|---|
Education |
Cornell University (
BS) Case Western Reserve University ( MD, PhD) |
Occupation(s) | Professor, surgeon, scientist |
Scientific career | |
Fields | |
Institutions | |
Military service | |
Allegiance | United States |
Service/ | United States Army |
Rank | Colonel |
Battles/wars | |
Awards |
|
Michael B. Yaffe is an American scientist, professor, surgeon, and retired U.S. Army Reserve Medical Corps Colonel. He is currently the David H. Koch Professor of Biology & Biological Engineering at MIT and a trauma surgeon at the Beth Israel Deaconess Medical Center. [1] In 2016, the United States Army awarded him the Bronze Star Medal for his services as a trauma surgeon on active duty in Afghanistan. [2] He also treated many of the victims of the Boston Marathon bombing. [3]
Yaffe graduated from Pikesville High School in Baltimore, MD in 1977. He received a B.S. in Materials Science & Engineering from Cornell University in 1981, and his Ph.D. and M.D. from Case Western Reserve University in 1987 and 1989, respectively. He then completed a residency at University Hospitals Cleveland Medical Center and Beth Israel Deaconess Medical Center, as well as a postdoctoral fellowship at Harvard Medical School. [4]
The main focus of Yaffe's research is decoding natural cell signaling pathway behavior using bioinformatics, combinatorial chemistry, cell biology, physical biochemistry, structural biology and molecular genetics. [5] The stated goal of his team's research is to "understand how signaling pathways are integrated at the molecular and systems level to control cellular responses." [6]
Besides his professorship at MIT, Yaffe is also an attending surgeon at the Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School, and the Chief Scientific Editor of the peer-reviewed science journal Science Signaling, published by the American Association for the Advancement of Science. [7] He is a co-founder of Consensus Pharmaceuticals, Merrimack Pharmaceuticals, On-Q-ity, the DNA Repair Company, Applied Biomath, and Thrombo-Therapeutics where he also serves as a member of its scientific advisory board. [4]
He currently has a number of highly cited articles. Two of Yaffe's papers have over 850 citations, and several others have over 400 citations. [8]